Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3043525	li-hsvab	— (—)	558	636	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Inflammatory diseases of the central nervous system

32.82

153.87

1.3

1.1

—

Viral infections of the central nervous system

30.21

142.36

1.3

1.2

—

Viral infections of the central nervous system

31.58

141.25

1.3

1.2

—

Epilepsy

120

108

11.15

113.60

1.2

1.1

—

Convulsions, not elsewhere classified

15.16

98.41

1.2

1.1

—

Focal epilepsy

9.86

78.28

1.2

1.1

—

Focal epilepsy, strict definition

10.08

76.02

1.2

1.1

—

Headache

136

169

6.44

75.66

1.1

—

Meningitis

27.87

72.08

1.3

1.2

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

9.96

70.98

1.2

1.1

—

Other symptoms and signs involving cognitive functions and awareness

122

179

6.23

69.46

1.2

1.1

—

General symptoms and signs

188

192

4.91

65.00

1.1

—

Fever of other and unknown origin

113

162

6.22

63.78

1.2

1.1

—

Neurological diseases

128

7.24

61.83

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

178

323

3.76

51.27

1.2

1.1

—

Intracranial trauma

8.45

50.92

1.1

1.0

—

Other encephalitis

84.41

50.42

1.4

1.1

—

Viral encephalitis, not elsewhere classified/unspecified

68.25

49.98

1.4

1.2

—

Malaise and fatigue

133

5.88

49.82

1.1

—

Encephalitis

66.52

49.70

1.4

1.2

—

Cerebrovascular diseases

148

251

4.15

49.02

1.2

1.1

—

Certain infectious and parasitic diseases

148

165

4.50

46.80

1.1

—

Sequelae of cerebrovascular disease

141

5.47

43.61

1.2

1.1

—

Concussion

8.04

42.15

1.1

1.0

—

Bacterial infection, other or unspecified

119

252

4.00

40.13

1.2

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

6.53

39.04

1.1

1.2

—

Implicit Sepsis

143

301

3.48

37.87

1.2

1.1

—

Bacterial infection, other or unspecified

110

239

4.00

37.45

1.2

1.1

—

Neurological diseases, wide definition

15.09

36.66

1.2

1.1

—

Implicit Sepsis

135

292

3.49

36.36

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

144

305

3.34

35.49

1.1

—

Episodal and paroxysmal disorders

159

244

3.32

34.66

1.2

1.1

—

Speech disturbances, not elsewhere classified

10.09

34.49

1.2

—

Stroke, including SAH

118

234

3.67

33.68

1.2

1.1

—

Stroke, excluding SAH

115

226

3.72

33.60

1.2

1.1

—

Medical observation and evaluation for suspected diseases and conditions

110

133

4.24

32.99

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

145

316

3.17

32.76

1.2

1.1

—

Other degenerative diseases of the nervous system

9.36

32.61

1.1

1.0

—

Status epilepticus

41.08

32.24

1.2

—

Implicit viral Sepsis

6.37

31.52

1.2

1.1

—

Viral Sepsis

6.37

31.52

1.2

1.1

—

Anaemias

8.98

31.41

1.2

1.0

—

Implicit bacterial Sepsis

172

4.24

30.35

1.1

—

Implicit viral Sepsis

128

5.02

30.20

1.2

1.1

—

Cerebrovascular diseases (FINNGEN)

5.17

30.06

1.1

—

Bacterial Sepsis

192

3.97

29.93

1.1

—

Continuous positive airway pressure

7.00

29.56

1.2

1.1

—

Spirochaetal infections, other/unspecified

9.08

29.48

1.1

1.2

—

Other and unspecified polyneuropathies, also in other diseases

5.89

28.62

1.1

1.2

—

Other bacterial diseases

147

343

2.88

28.27

1.2

1.1

—

Implicit bacterial Sepsis

188

3.91

28.15

1.1

—

Ischaemic Stroke, excluding all haemorrhages

102

223

3.41

26.55

1.2

1.1

—

Other neurological diseases

121

315

3.02

26.42

1.2

1.1

—

Other bacterial diseases

150

346

2.75

26.15

1.2

1.1

—

Visual disturbances and blindness

275

3.39

26.03

1.2

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

7.53

25.38

1.3

1.2

—

Migraine

142

4.12

25.06

1.2

1.1

—

Influenza and pneumonia

154

375

2.61

24.40

1.1

—

Other spirochaetal diseases

147

4.23

23.85

1.1

1.2

—

Other spirochaetal diseases

149

4.17

23.44

1.1

1.2

—

Pneumonia, organism unspecified

136

355

2.69

23.40

1.1

—

Dizziness and giddiness

107

283

3.00

23.19

1.1

—

Lyme disease

147

4.16

22.98

1.1

1.2

—

Spirochaetal infections, other/unspecified

147

4.16

22.98

1.1

1.2

—

STROKE

190

3.33

22.80

1.2

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

152

339

2.51

21.49

1.1

—

All kidney diseases

142

385

2.52

21.48

1.1

—

ILD medications: immunosuppressive drugs

300

2.98

21.41

1.2

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

316

2.98

21.35

1.1

—

128

288

2.69

21.24

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

128

288

2.69

21.24

1.1

—

Certain infectious and parasitic diseases

125

3.53

21.00

1.2

1.1

—

Hydrocephalus

8.73

20.66

1.1

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

139

383

2.48

20.28

1.1

—

Organic, including symptomatic, mental disorders

196

3.17

20.03

1.2

—

ILD medications

153

345

2.41

19.71

1.1

—

GASTRO-related operations

154

3.13

19.31

1.2

1.1

—

Any gastric operation

154

3.13

19.31

1.2

1.1

—

All pneumoniae

139

384

2.42

19.25

1.1

—

Viral meningitis

26.43

19.15

1.5

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

138

383

2.42

19.14

1.1

—

Diseases of the myoneural junction and muscle

6.03

19.01

1.2

—

Syncope and collapse

126

3.88

18.75

1.2

1.1

—

Visual disturbances

256

3.05

18.56

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

133

3.26

18.06

1.1

—

Renal tubulo-interstitial diseases

122

372

2.44

17.77

1.1

—

Abnormal findings on diagnostic imaging of central nervous system

13.83

17.76

1.3

—

Infections, IBD-co-morbidities

18.88

17.66

1.1

—

Pneumonitis due to solids and liquids

7.40

17.37

1.2

1.3

—

Viral infections characterized by skin and mucous membrane lesions

217

3.14

16.97

1.3

1.1

—

Injuries to the head

147

404

2.24

16.81

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

151

3.54

16.71

1.2

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

133

3.12

16.58

1.2

1.1

—

Explicit Sepsis

195

3.17

16.46

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

132

398

2.29

16.39

1.2

1.1

—

Cerebral palsy and other paralytic syndromes

5.98

16.03

1.3

1.2

—

Oedema, not elsewhere classified

4.22

15.78

1.2

—

Other and unspecified myopathies

6.62

15.74

1.2

—

Persons encountering health services in other circumstances

217

3.03

15.57

1.2

1.1

—

First line medication for Crohn's disease

139

336

2.24

15.38

1.1

—

Other headache syndromes

147

3.47

15.01

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases

135

332

2.22

14.74

1.1

1.2

—

Symptoms and signs involving speech and voice

164

3.30

14.69

1.2

1.1

—

Inflammatory bowel disease treatment related agents

146

382

2.14

14.69

1.2

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

347

2.45

14.63

1.2

1.1

—

Other antidepressants

131

299

2.25

14.43

1.2

1.1

—

Acute tubulo-interstitial nephritis

310

2.51

14.42

1.2

—

Oral corticosteroids

137

377

2.16

14.31

1.1

—

Symptoms and signs involving the urinary system

105

340

2.36

14.30

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.16

14.09

1.2

1.1

—

Systemic connective tissue disorders

170

3.18

13.89

1.1

—

Iron deficiency anaemia

224

2.86

13.88

1.2

1.1

—

Bacterial meningitis

17.76

13.85

1.1

—

Zoster [herpes zoster]

4.20

13.84

1.3

1.1

—

Nausea and vomiting

124

3.56

13.72

1.2

1.1

—

Autoimmune diseases related-to ILD

111

427

2.23

13.64

1.1

1.2

—

Hypo-osmolality and hyponatraemia

4.29

13.43

1.1

1.2

—

Tramadol

102

265

2.37

13.34

1.1

1.2

—

Septicaemia

196

2.92

13.31

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

128

325

2.16

13.15

1.1

1.2

—

Other diseases of urinary system

126

329

2.15

12.98

1.2

1.1

—

Other and unspecified iron deficiency

164

3.11

12.68

1.1

—

Diplopia

4.76

12.58

1.1

1.2

—

L04AX Other immunosuppressants

311

2.48

12.48

1.1

—

Other septicaemia

179

2.96

12.43

1.1

—

Herpesviral [herpes simplex] infections

4.84

12.36

1.3

1.1

—

Lung diseases due to external agents

4.84

12.35

1.2

—

Second line medication for Crohn's disease

319

2.45

12.31

1.1

—

Intracranial injury

308

2.43

12.14

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

218

2.76

12.04

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

109

3.57

12.02

1.1

—

Paralytic strabismus

8.69

11.99

1.1

1.2

—

Guillain-Barre syndrome

30.71

11.69

1.1

1.6

—

Other disorders of urethra and urinary system

273

2.33

11.64

1.2

1.1

—

Nerve, nerve root and plexus disorders

131

401

2.00

11.50

1.2

1.1

—

Pain in joint

186

2.54

11.38

1.2

—

Fitting and adjustment of other devices

172

2.84

11.21

1.1

1.2

—

Fall on same level

137

380

1.97

11.18

1.1

—

Diseases of the eye and adnexa

200

2.33

11.17

1.2

—

Glomerular disorders in diseases classified elsewhere

5.02

10.98

1.1

1.2

—

Nutritional anaemias

260

2.49

10.92

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

176

2.49

10.89

1.1

—

COPD/asthma/ILD related infections

119

288

2.07

10.84

1.2

1.1

—

COPD/asthma related infections

119

288

2.07

10.84

1.2

1.1

—

Persons encountering health services for examination and investigation

133

2.64

10.80

1.1

—

Bleeding

105

358

2.09

10.70

1.1

1.2

—

Abnormalities of gait and mobility

4.56

10.70

1.0

1.2

—

Benzodiazepine use

122

425

1.98

10.67

1.1

1.2

—

Diagnoses used for exclusion with ILD

124

3.23

10.63

1.3

1.1

—

All influenza

100

3.51

10.55

1.1

—

Oxycodone

199

2.64

10.54

1.1

1.2

—

Exclusions for E4_PCOS_BROAD

3.90

10.53

1.3

1.1

—

Used for control exclusion in common control thyroid runs

121

302

2.03

10.46

1.1

—

Strabismus

131

3.13

10.33

1.2

1.1

—

Enlarged lymph nodes

5.13

10.29

1.1

1.2

—

Examination and observation for other reasons

132

2.68

10.13

1.2

1.1

—

Migraine with aura

3.71

9.84

1.2

1.1

—

Other systemic involvement of connective tissue (FG)

109

3.27

9.72

1.1

1.2

—

Psychiatric diseases

114

284

2.01

9.70

1.1

—

Dementia, including avohilmo

169

2.53

9.69

1.1

1.2

—

Cardiovascular diseases

147

2.49

9.62

1.2

1.1

—

ILD medications: azathioprine

4.18

9.62

1.2

—

Complications of surgical and medical care, not elsewhere classified

118

420

1.93

9.61

1.2

1.1

—

Viral infections characterized by skin and mucous membrane lesions

103

444

1.98

9.56

1.3

1.1

—

Other specific joint derangements/joint disorders

273

2.13

9.51

1.1

—

Falls/tendency to fall

124

321

1.94

9.50

1.1

1.2

—

Migraine without aura

4.01

9.48

1.1

—

Other reaction to severe stress, and adjustment disorders

177

2.72

9.46

1.1

1.2

—

Low back pain

313

2.09

9.37

1.2

—

Intestinal infectious diseases

111

436

1.93

9.35

1.1

1.2

—

Disorders of thyroid, IBD co-morbidities

11.51

9.35

1.1

—

Dysphagia

121

3.06

9.05

1.2

1.1

—

Demyelinating diseases of the central nervous system

4.78

9.05

1.1

1.2

—

Any death

265

2.16

9.01

1.1

1.2

—

Provisional assignment of new diseases of uncertain etiology

290

2.27

8.97

1.2

1.1

—

Autoimmune diseases

124

334

1.89

8.93

1.1

1.2

—

Visual impairment including blindness (binocular or monocular)

7.45

8.92

1.3

1.2

—

Bell's palsy

4.20

8.90

1.1

1.2

—

Codes for special purposes

291

2.27

8.90

1.2

1.1

—

Dementia

156

2.52

8.89

1.1

1.2

—

Dorsalgia

115

320

1.93

8.88

1.1

1.2

—

Azathioprine

3.92

8.85

1.2

—

Presence of other devices

107

3.17

8.81

1.2

1.1

—

Traumatic subdural haemorrhage

8.66

8.74

1.1

1.0

—

Zoster [herpes zoster]

277

2.28

8.71

1.3

1.1

—

Complications of medical and surgical care

402

2.01

8.68

1.2

1.1

—

Parkinson's disease, excluding more controls

9.44

8.64

1.1

1.0

—

Herpesviral [herpes simplex] infections

114

3.08

8.64

1.3

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

359

2.06

8.55

1.1

—

Other disorders of lacrimal gland

187

2.57

8.53

1.2

1.1

—

Other systemic involvement of connective tissue

131

2.91

8.51

1.1

—

Intestinal infectious diseases

129

406

1.82

8.50

1.1

1.2

—

Opioids

108

289

1.94

8.50

1.1

—

Nontraumatic intracranial haemmorrhage

3.51

8.49

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

107

326

1.92

8.47

1.1

—

Depression medications

4.05

8.46

1.2

1.0

—

Glomerular diseases

3.38

8.33

1.1

1.2

—

All chronic kidney diseases

242

2.23

8.28

1.1

1.2

—

Moderate visual impairment, binocular

14.58

8.21

1.2

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

105

2.78

8.20

1.0

1.1

—

Codeine

102

285

1.95

8.18

1.1

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

244

2.32

8.12

1.2

1.1

—

Other demyelinating diseases of the central nervous system

11.76

8.08

1.1

1.5

—

Follow-up care involving plastic surgery

11.76

8.07

1.1

1.5

—

Insulin medication

303

2.08

8.00

1.2

1.1

—

Parkinson's disease, strict definition, excluding more controls

8.98

7.98

1.1

1.0

—

Sleep apnoea

107

371

1.87

7.96

1.1

—

Excluding asthma or asthma-COPD overlap

189

2.12

7.89

1.2

1.1

—

COPD differential diagnosis

190

2.11

7.79

1.2

1.1

—

ILD differential diagnosis

190

2.11

7.79

1.2

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

144

2.71

7.73

1.1

—

Exposure to other specified factors

419

1.93

7.73

1.2

1.1

—

Parasetamol

187

2.11

7.67

1.2

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

337

2.04

7.66

1.2

1.1

—

Other and unspecified degenerative diseases of nervous system

18.52

7.61

1.1

1.2

—

Antihypertensive medication - note that there are other indications

156

2.24

7.57

1.2

1.1

—

Complications of procedures, not elsewhere classified

403

1.89

7.48

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

106

377

1.83

7.46

1.2

1.1

—

Insulin, intermediate and long-acting

318

2.08

7.45

1.2

1.1

—

Metabolic disorders

103

339

1.85

7.43

1.2

1.1

—

Polyarthropathies

251

2.03

7.41

1.1

1.2

—

Chronic kidney disease

156

2.58

7.37

1.1

1.2

—

Anxiety disorders, excluding more controls

291

1.95

7.35

1.1

—

Cervicalgia

3.04

7.29

1.1

1.2

—

Abnormalities of heart beat

192

2.40

7.28

1.2

1.1

—

Other pulmonary diagnosis

189

2.07

7.26

1.2

1.1

—

Pain, not elsewhere classified

3.48

7.24

1.3

1.1

—

Other symptoms and signs involving general sensations and perceptions

15.81

7.23

1.0

1.4

—

Other viral diseases

149

2.61

7.21

1.2

1.1

—

Any mental disorder

116

324

1.79

7.20

1.2

1.1

—

Disorders of lacrimal system

234

2.26

7.19

1.2

1.1

—

Other dorsopathies, not elsewhere classified

111

321

1.81

7.18

1.1

—

Other viral diseases

184

2.43

7.16

1.2

1.1

—

Sensorineural hearing loss

303

1.93

7.15

1.1

1.2

—

Hard cardiovascular diseases

276

1.92

7.14

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

6.57

7.10

1.1

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

110

408

1.78

7.08

1.1

1.2

—

Sleep disorders (combined)

122

366

1.75

7.08

1.1

—

Insulin, fast-acting

187

2.41

7.04

1.2

1.1

—

Mood disorders, excluding more controls

317

1.85

6.97

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.39

6.95

1.2

1.1

—

Retention of urine

152

2.43

6.92

1.2

—

Cystitis

287

1.89

6.90

1.2

1.1

—

Malignant neoplasm of brain, including Hilmo

7.55

6.90

1.1

1.4

—

Impacted cerumen

3.97

6.88

1.1

1.2

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.44

6.82

1.1

1.2

—

Sixth [abducent] nerve palsy

11.00

6.80

1.1

1.4

—

Third [oculomotor] nerve palsy

16.90

6.76

1.1

1.7

—

Insulin, fast-acting or short human

197

2.34

6.75

1.2

1.1

—

Disorders of optic nerve and visual pathways

3.89

6.70

1.2

—

Cerebral cysts

7.18

6.70

1.1

1.3

—

Intracerebral haemorrhage

3.89

6.70

1.0

1.2

—

Cellulitis

110

2.82

6.66

1.2

1.1

—

Pulmonary embolism

133

2.63

6.61

1.1

1.2

—

Type 1 diabetes

116

2.76

6.59

1.1

—

Any reimbursement code in KELA

130

2.24

6.56

1.1

—

Special screening examination for infectious and parasitic diseases

3.25

6.54

1.2

1.1

—

Covid-19 confirmed case

194

2.32

6.53

1.3

1.1

—

Other mental disorders due to brain damage and dysfunction and to physical disease

3.81

6.52

1.3

1.2

—

Unspecified fall

280

2.08

6.52

1.2

1.1

—

Pulmonary heart disease

134

2.62

6.52

1.1

1.2

—

Sleep apnoea, including avohilmo

108

383

1.75

6.51

1.1

—

Other necrotizing vasculopathies (FG)

6.85

6.51

1.1

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

401

1.88

6.41

1.2

1.1

—

Neurotic, stress-related and somatoform disorders

366

1.80

6.40

1.1

—

Brain glioblastoma

18.29

6.28

1.1

1.4

—

Exposure to unspecified factor

107

449

1.72

6.26

1.1

1.2

—

Other CVD (FINNGEN)

4.26

6.24

1.1

—

Disorders of eyelid, lacrimal system and orbit

397

1.78

6.24

1.2

1.1

—

Normal-pressure hydrocephalus

7.04

6.22

1.1

1.3

—

Anxiety disorders

368

1.78

6.21

1.1

—

Polycystic ovarian syndrome, consortium definition

213

1.98

6.19

1.2

1.1

—

Finngen Rheumatological endpoints

101

326

1.76

6.18

1.1

—

Conductive and sensorineural hearing loss

327

1.82

6.17

1.1

1.2

—

Other disorders of skin and subcutaneous tissue

368

1.86

6.13

1.1

—

Brain glioblastoma and astrocytoma

12.67

6.09

1.1

1.6

—

Accidents

224

1.88

6.09

1.2

1.1

—

Cervical disc disorders

194

2.27

6.09

1.1

1.2

—

Malignant neoplasm of eye, brain and central nervous system

8.62

6.05

1.1

1.4

—

Disorders of other endocrine glands

229

2.15

6.05

1.2

1.1

—

Disorders of speech understanding and production

7.55

6.03

1.4

1.3

—

Disorders of psychological development

3.95

6.01

1.3

1.2

—

L04AA Selective immunosuppressants

111

2.71

6.00

1.2

1.1

—

Diseases of the skin and subcutaneous tissue

104

299

1.75

5.99

1.1

—

Heart failure, not strict

308

1.83

5.99

1.1

1.2

—

Diseases of external ear

177

2.32

5.96

1.2

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

359

1.90

5.96

1.1

—

Infections of the skin and subcutaneous tissue

340

1.92

5.93

1.1

—

Liquid cancers, helper endpoint

186

2.21

5.93

1.1

1.2

—

Secondary hypertension

5.94

5.92

1.1

—

Persons encountering health services in other circumstances, wide

121

375

1.66

5.90

1.2

1.1

—

Symptoms and signs involving the digestive system and abdomen

105

304

1.73

5.89

1.2

1.1

—

Mycoses

130

2.54

5.84

1.2

—

Vitamin deficiency

8.04

5.84

1.1

1.3

—

Vitamin deficiency, wide

8.04

5.84

1.1

1.3

—

Other external causes of accidental injury

224

1.86

5.83

1.2

1.1

—

Myalgia

113

2.66

5.80

1.1

1.2

—

Type 1 diabetes, wide definition, subgroup 1

2.81

5.80

1.1

—

Disturbances of skin sensation

137

2.49

5.75

1.1

—

Migraine without aura and triptan purchases

3.07

5.75

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

120

2.59

5.69

1.1

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

5.58

5.68

1.2

1.3

—

Disorders of lens

242

1.88

5.66

1.2

—

Presence of other functional implants

237

1.93

5.65

1.1

1.2

—

Pain (limb, back, neck, head abdominally)

191

1.92

5.63

1.2

1.1

—

Unspecified urinary incontinence

4.74

5.60

1.2

—

Malignant neoplasm of brain

8.52

5.56

1.1

1.5

—

Other female pelvic inflammatory diseases

2.99

5.52

1.3

1.1

—

Type 2 diabetes, wide definition

302

1.78

5.51

1.1

—

N06DA Anticholinesterases

137

2.30

5.50

1.1

—

Use of anticholinesterases

137

2.30

5.50

1.1

—

Budesonide

3.34

5.43

1.2

—

Substance abuse, excluding more controls

258

1.95

5.42

1.2

1.1

—

Specific development disorders of speech and language

6.28

5.38

1.4

1.3

—

MS-disease / Multiple Sclerosis

5.19

5.38

1.0

1.2

—

Inflammatory diseases of female pelvic organs

227

1.94

5.31

1.2

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

292

1.93

5.30

1.1

—

Other necrotizing vasculopathies

4.73

5.29

1.1

1.2

—

Hemiplegia

6.70

5.25

1.1

1.3

—

Renal failure

241

1.98

5.24

1.1

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

182

2.20

5.19

1.3

1.1

—

Triptan medication for migraine, min. 3 purchases

228

1.94

5.17

1.2

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

346

1.85

5.16

1.2

1.1

—

Non-Hodgkin lymphoma, all, including Hilmo

3.23

5.16

1.1

1.2

—

Other and unspecified anaemias

224

2.04

5.13

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

328

1.76

5.13

1.1

—

Type 1 diabetes, wide definition

103

2.62

5.12

1.1

—

Speech and linguistic disorders, excluding more controls

5.84

5.11

1.4

1.2

—

Gastro-oesophageal reflux disease

360

1.77

5.11

1.2

1.1

—

Other anaemias

224

2.04

5.10

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

158

2.28

5.09

1.1

1.2

—

Abnormal findings on diagnostic imaging of lung

266

1.95

5.06

1.2

1.1

—

All influenza (not pneumonia)

3.17

5.03

1.0

1.2

—

Diseases of the respiratory system

160

1.94

5.02

1.2

1.1

—

Diseases of the musculoskeletal system and connective tissue

136

2.03

5.01

1.1

—

Recurrent or chronic depression

113

2.30

4.98

1.1

—

Aplastic and other anaemias

247

1.96

4.98

1.1

—

Internal derangement of knee

191

2.14

4.97

1.3

1.1

—

Other viral diseases, not elsewhere classified

128

2.41

4.96

1.2

1.1

—

Endocrine, nutritional and metabolic diseases

221

1.79

4.95

1.1

—

Codeine or tramadol medication

117

403

1.59

4.94

1.2

1.1

—

Hypertensive diseases (excluding secondary)

149

2.03

4.93

1.1

—

Visual field defects

4.34

4.93

1.1

1.2

—

Abnormal involuntary movements

3.12

4.90

1.2

—

Other functional intestinal disorders

248

1.95

4.86

1.1

—

Somnolence, stupor and coma

7.73

4.85

1.4

1.2

—

Extrapyramidal and movement disorders

201

2.09

4.83

1.1

1.2

—

Injuries to the knee and lower leg

121

429

1.57

4.83

1.2

1.1

—

Missing teeth due to accident, extraction or parodontitis

340

1.80

4.82

1.3

1.1

—

Other viral diseases, not elsewhere classified

2.69

4.80

1.2

1.1

—

Superficial injury of head

113

2.48

4.77

1.1

1.2

—

External causes of morbidity and mortality

174

1.87

4.76

1.2

1.1

—

Heartburn

3.58

4.76

1.2

1.1

—

Diabetic maculopathy, excluding more controls

3.41

4.74

1.1

1.2

—

Other specified/unspecified arthritis

132

2.35

4.72

1.1

1.2

—

Senile cataract

226

1.82

4.71

1.2

—

Gastrointestinal diseases

157

1.92

4.70

1.2

1.1

—

Unspecific neurodegenerative disorder

158

2.03

4.68

1.1

1.2

—

Pure hypercholesterolaemia

276

1.75

4.67

1.2

1.1

—

Alzheimer disease, excluding more controls

5.13

4.67

1.2

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

158

2.22

4.67

1.1

—

Diabetic retinopathy, strict definition

2.69

4.66

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.60

4.65

1.0

1.1

—

Other medical care

238

1.93

4.63

1.2

1.1

—

Benign neoplasm of meninges

3.50

4.61

1.1

1.2

—

Generalized anxiety disorder

2.90

4.59

1.3

1.1

—

Other abnormal uterine and vaginal bleeding

2.48

4.59

1.2

1.1

—

Other disorders of ear

368

1.64

4.58

1.1

—

Other arthritis (FG)

153

2.22

4.57

1.1

1.2

—

Diabetic nephropathy, excluding more controls

2.89

4.56

1.0

1.1

—

Early onset COPD, excluding more controls

2.80

4.53

1.2

1.1

—

SLE (Finngen)

10.05

4.52

1.1

1.6

—

Dorsopathies

102

322

1.61

4.51

1.1

1.2

—

Selective serotonin reuptake inhibitors

299

1.64

4.51

1.2

1.1

—

Disorders of choroid and retina

365

1.66

4.49

1.1

—

Crohn disease

2.86

4.48

1.1

1.2

—

Aneurysms, operations, SAH

2.86

4.48

1.1

1.2

—

Type of accident

142

2.26

4.45

1.1

—

Speech and linguistic disorders

4.81

4.45

1.4

1.2

—

Diabetes medication

103

385

1.59

4.44

1.1

—

Alcohol withdrawal state with delirium

4.39

4.43

1.3

1.2

—

Abdominal and pelvic pain

304

1.62

4.43

1.1

—

Arthropathies

280

1.65

4.40

1.1

—

Insulin, fast-acting (human)

3.01

4.39

1.2

—

Mood [affective] disorders

102

419

1.58

4.38

1.1

—

Subjective visual disturbances

118

2.38

4.38

1.1

—

Certain disorders involving the immune mechanism

2.56

4.37

1.4

1.1

—

DVT of lower extremities and pulmonary embolism

229

1.96

4.37

1.1

1.2

—

Mood disorders

102

419

1.58

4.36

1.1

—

Pain in throat and chest

304

1.66

4.35

1.2

1.1

—

Postprocedural disorders of nervous system

5.01

4.31

1.1

1.3

—

Papilloedema, unspecified

8.96

4.28

1.1

1.6

—

Nystagmus and other irregular eye movements

11.79

4.28

1.3

1.7

—

Transient ischemic attack

225

1.87

4.27

1.2

1.1

—

Dermatitis

360

1.74

4.27

1.2

1.1

—

Other diseases of intestines

105

382

1.56

4.24

1.1

—

Sequelae of infectious and parasitic diseases

4.50

4.24

1.4

1.2

—

Pain in limb

318

1.66

4.22

1.2

1.1

—

Other disorders of glucose regulation and pancreatic internal secretion

4.13

4.20

1.1

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

312

1.59

4.18

1.1

—

Other nutritional deficiencies

363

1.71

4.17

1.2

1.1

—

Factors influencing health status and contact with health services

2.51

4.15

1.2

1.1

—

Use of rivastigmine

2.90

4.14

1.1

1.2

—

Dermatitis due to substances taken internally

5.26

4.14

1.3

—

Persons encountering health services for specific procedures and health care

103

397

1.56

4.13

1.1

—

Diffuse large B-cell lymphoma, helper endpoint

5.91

4.13

1.1

1.4

—

Diffuse large B-cell lymphoma, including Hilmo

5.91

4.13

1.1

1.4

—

Diffuse large B-cell lymphoma

5.91

4.13

1.1

1.4

—

Acute generalized exanthematous pustulosis

5.91

4.13

1.3

1.4

—

322

1.74

4.12

1.2

1.1

—

Other disorders of eye and adnexa

2.80

4.11

1.3

1.2

—

Open wound of wrist and hand

244

1.88

4.09

1.1

—

Open wound of head

289

1.80

4.08

1.2

1.1

—

Undefined dementia

3.40

4.06

1.1

1.3

—

Other heart diseases

150

1.96

4.06

1.1

—

Hypoglycaemia, other or unspecified

4.63

4.05

1.2

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

257

1.86

4.03

1.2

1.1

—

Injuries to the ankle and foot

366

1.68

4.01

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

195

1.99

4.00

1.1

—

Anogenital herpesviral [herpes simplex] infection

5.02

4.00

1.3

1.1

—

Infections with a predominantly sexual mode of transmission

149

2.15

3.99

1.2

1.1

—

Giant cell arteritis with polymyalgia rheumatica

6.46

3.98

1.2

1.3

—

Family history of certain disabilities and chronic diseases leading to disablement

6.45

3.98

1.2

1.1

—

severe traumatic brain injury, does not include concussion

111

2.35

3.98

1.0

1.2

—

Dementia in other diseases classified elsewhere

5.58

3.97

1.0

1.3

—

Depression

402

1.57

3.97

1.1

1.2

—

Sub-endpoint used in defining T1D endpoints

147

2.14

3.96

1.1

—

Neoplasms

241

1.67

3.96

1.1

—

Alcohol use disorder, Swedish definition

305

1.74

3.91

1.2

1.1

—

Diseases of oesophagus, stomach and duodenum

105

411

1.53

3.91

1.2

1.1

—

Caries of dentine

121

2.25

3.90

1.1

—

Crohn's disease NAS

4.08

3.90

1.1

1.2

—

Triptan medication for migraine, single purchase ok

288

1.67

3.90

1.2

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

288

1.67

3.90

1.2

1.1

—

Deviated nasal septum

191

1.99

3.89

1.2

1.1

—

Injuries to the shoulder and upper arm

427

1.59

3.88

1.2

1.1

—

Striking against or struck by other objects

171

2.05

3.87

1.2

1.1

—

Genitourinary diseases

154

1.82

3.87

1.2

1.1

—

Decubitus ulcer and pressure area

4.80

3.87

1.0

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.80

3.87

1.1

1.2

—

Chronic lymphocytic leukaemia

7.32

3.86

1.1

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

7.32

3.86

1.1

1.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

7.32

3.86

1.1

1.3

—

Spondylopathies

285

1.64

3.86

1.2

—

Superficial injury of lower leg

119

2.27

3.86

1.1

—

Hypokalaemia

2.97

3.84

1.3

1.1

—

Enterocolitis due to Clostridium difficile

2.97

3.84

1.0

1.2

—

Temporal arteritis

6.03

3.82

1.2

1.3

—

Depression or dysthymia

188

1.76

3.81

1.1

—

Problems related to lifestyle

3.07

3.80

1.5

1.1

—

Other disorders of patella

2.60

3.80

1.2

—

Care involving dialysis

3.70

3.79

1.2

—

Diseases of the ear and mastoid process

108

357

1.52

3.79

1.2

1.1

—

Use of levodopa decarboxylase inhibitor

2.84

3.78

1.1

1.2

—

Monoplegia

8.84

3.78

1.7

1.5

—

Any dementia, excluding more controls

125

2.04

3.78

1.2

1.1

—

Paraplegia, diplegia of upper limbs

8.81

3.78

1.1

1.5

—

Complications of genitourinary prosthetic devices, implants and grafts

8.80

3.77

1.0

1.6

—

329

1.69

3.77

1.2

1.1

—

Diseases of liver

180

2.00

3.76

1.2

—

Bronchitis

103

428

1.52

3.76

1.1

1.2

—

Injury, poisoning and certain other consequences of external causes

134

1.87

3.74

1.2

1.1

—

Post-traumatic stress disorder

4.59

3.74

1.4

1.2

—

Injuries to the thorax

258

1.82

3.73

1.1

—

Cutaneous abscess, furuncle and carbuncle

128

2.19

3.69

1.3

1.1

—

Dermatitis and eczema

107

443

1.50

3.68

1.1

—

Polymyalgia rheumatica

2.79

3.68

1.1

1.2

—

Allergic contact dermatitis

2.79

3.68

1.1

1.2

—

Disorder of external ear, unspecified

6.70

3.67

1.1

1.5

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

5.65

3.66

1.1

1.3

—

Conjunctivitis (acute, non atopic)

141

2.12

3.66

1.1

1.2

—

Inflammatory diseases of prostate (prostatitis)

2.69

3.65

1.2

—

Unspecified dementia

3.60

3.65

1.1

1.2

—

Bacterial, viral and other infectious agents

3.12

3.64

1.0

1.2

—

Other disorders of bladder

3.12

3.64

1.1

1.2

—

Seronegative rheumatoid arthritis

3.12

3.64

1.0

1.2

—

Other symptoms and signs involving the digestive system and abdomen

2.61

3.63

1.1

—

Lower back pain or/and sciatica

102

443

1.50

3.62

1.2

1.1

—

Type 2 diabetes

362

1.53

3.61

1.1

—

Other joint disorders

280

1.58

3.58

1.1

—

Diabetic retinopathy, excluding more controls

2.22

3.57

1.1

—

Anaemia in chronic diseases classified elsewhere

7.83

3.56

1.1

1.4

—

Hidradenitis suppurativa

7.81

3.56

1.1

1.4

—

Diabetes mellitus

378

1.52

3.54

1.1

—

Mental and behavioural disorders due to alcohol

295

1.73

3.52

1.2

1.1

—

Non-follicular lymphoma

3.05

3.52

1.1

1.2

—

Anogenital herpesviral [herpes simplex] infection

3.05

3.52

1.2

1.1

—

Other dialysis

5.33

3.51

1.1

1.3

—

Generalized skin eruption due to drugs and medicaments

5.32

3.51

1.3

1.4

—

Giant cell arteritis

5.32

3.51

1.2

—

Erysipelas

252

1.76

3.48

1.1

—

Erysipelas

302

1.64

3.48

1.1

—

Suicide or other Intentional self-harm

125

2.16

3.46

1.0

1.2

—

Other retinal disorders

303

1.65

3.46

1.1

—

Other bacterial intestinal infections

2.47

3.45

1.1

1.2

—

Diabetes, varying definitions

377

1.51

3.45

1.1

—

Hypothyroidism (congenital or acquired)

2.83

3.45

1.2

1.0

—

Unspecified haematuria

194

1.84

3.43

1.0

1.2

—

Polyuria

119

2.19

3.43

1.1

1.2

—

Other intervertebral disc disorders

302

1.58

3.42

1.1

1.2

—

Asthma, unspecified (mode), excluding more controls

169

1.86

3.41

1.3

1.1

—

Mental and behavioural disorders due to psychoactive substance use

343

1.65

3.41

1.2

1.1

—

Bacterial, viral and other infectious agents

2.99

3.41

1.0

1.2

—

Hernia of abdominal wall, postoperative

2.98

3.40

1.1

—

Disorders of skin appendages

266

1.77

3.40

1.2

1.1

—

Other problems related to primary support group, including family circumstances

2.87

3.39

1.3

1.1

—

Misadventures to patients during surgical and medical care

2.66

3.39

1.4

1.2

—

Asthma, excluding more controls

176

1.72

3.38

1.3

1.1

—

Other Crohn's disease

3.76

3.38

1.0

1.2

—

Diseases of tongue

5.01

3.37

1.1

1.2

—

Other shoulder lesions

3.10

3.36

1.1

1.2

—

Chorioretinal inflammation

7.03

3.36

1.0

1.4

—

Systemic lupus erythematosus

5.74

3.34

1.1

1.4

—

Fungal Sepsis

5.74

3.34

1.0

1.2

—

Asthma (mode)

190

1.69

3.33

1.3

1.1

—

Dental caries

135

2.07

3.31

1.1

—

Leisure time condition

2.36

3.31

1.1

—

Other (seronegative) rheumatoid arthritis, wide

2.36

3.31

1.0

1.1

—

Covid-19 suspected case

108

2.22

3.31

1.0

1.1

—

Implicit fungal Sepsis

4.36

3.30

1.1

1.2

—

Abnormalities of breathing

312

1.55

3.30

1.2

1.1

—

Dialysis, with operation codes

2.62

3.30

1.2

—

Chronic laryngitis and laryngotracheitis

2.62

3.29

1.3

1.1

—

Other disorders of nervous system

3.65

3.29

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.94

3.28

1.0

1.2

—

Crohn disease (strict definition, require KELA)

3.94

3.28

1.0

1.2

—

Soft tissue disorders

329

1.50

3.28

1.1

—

Other bacterial intestinal infections

102

2.26

3.28

1.1

1.2

—

Obstructive hydrocephalus

8.64

3.27

1.2

1.6

—

Myasthenia gravis

8.64

3.27

1.2

1.6

—

Asthma

187

1.68

3.26

1.3

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

4.69

3.26

1.2

1.0

—

Pain associated with micturition

2.78

3.25

1.1

1.2

—

Acute renal failure

109

2.20

3.24

1.0

1.2

—

Substance abuse

339

1.64

3.23

1.2

1.1

—

Chronic apical periodontitis

107

418

1.46

3.23

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

355

1.51

3.23

1.1

—

Disorders of mineral metabolism

3.34

3.22

1.1

1.2

—

Bipolar affective disorders

2.38

3.22

1.2

1.1

—

Infections with a predominantly sexual mode of transmission

184

1.87

3.22

1.2

1.1

—

Fracture of skull and facial bones

103

2.24

3.21

1.1

—

Colonic or urogenital fistula

136

2.06

3.21

1.1

1.2

—

Sequelae of other and unspecified infectious and parasitic diseases

4.18

3.19

1.5

1.2

—

Sacroiliitis, not elsewhere classified

5.35

3.19

1.1

1.4

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.80

3.18

1.0

1.2

—

Diabetic nephropathy

2.31

3.14

1.0

1.1

—

Any dementia

146

1.86

3.13

1.2

1.1

—

Elevated blood glucose level

3.44

3.10

1.0

1.2

—

Hypertension, essential

268

1.56

3.10

1.1

—

Tobacco use

4.01

3.08

1.5

1.2

—

Other specified/unspecified systemic involvement of connective tissue

4.01

3.08

1.1

1.3

—

Trigeminal neuralgia

4.01

3.08

1.0

1.2

—

Other anxiety disorders

192

1.81

3.08

1.2

1.1

—

Vocal cord dysfunction

3.24

3.08

1.2

1.1

—

Allergic asthma (mode), excluding more controls

2.52

3.07

1.1

—

Mycoses

469

1.50

3.07

1.1

—

Other and unspecified hydrocephalus

7.55

3.06

1.2

1.5

—

Amyloidosis

7.54

3.06

1.2

1.4

—

Volume depletion

3.18

3.05

1.1

1.2

—

Heart failure and antihypertensive medication

2.18

3.04

1.0

1.1

—

Parkinson's disease, strict definition

2.58

3.04

1.1

1.2

—

Other blood glucose lowering drugs, excl. Insulins

2.50

3.03

1.4

1.2

—

Superficial injury of hip and thigh

2.50

3.03

1.1

1.2

—

Coxibs

2.09

3.02

1.2

1.1

—

Schizophrenia or delusion, excluding more controls

138

2.01

3.01

1.0

1.1

—

Explicit bacterial Sepsis

3.34

3.01

1.2

—

Osteopathies and chondropathies

314

1.63

3.01

1.1

—

Diabetic neuropathy

2.57

3.00

1.1

—

Rheumatoid arthritis

143

1.95

3.00

1.1

1.2

—

Constipation

389

1.49

3.00

1.2

1.1

—

Bacterial intestinal infections, IBD co-morbidities

2.30

3.00

1.1

1.2

—

Candidiasis

140

2.00

2.99

1.1

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.56

2.99

1.0

1.2

—

Hypothyroidism, levothyroxine purchases

2.67

2.98

1.2

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.67

2.98

1.2

1.0

—

Other renal tubulo-interstitial diseases

10.04

2.98

1.2

1.6

—

Localized swelling, mass and lump of skin and subcutaneous tissue

161

1.93

2.98

1.3

1.1

—

Asthma, unspecified (mode)

179

1.77

2.95

1.3

1.1

—

Nephropathy related operations

2.54

2.95

1.1

1.2

—

Hypothyroidism, drug reimbursement

3.70

2.95

1.3

1.0

—

Pain in thoracic spine

2.54

2.95

1.1

1.2

—

Other CVD

2.27

2.92

1.1

1.2

—

Hepatic failure, not elsewhere classified

4.73

2.92

1.4

1.3

—

Monoarthritis, not elsewhere classified

4.72

2.92

1.3

1.2

—

Other infectious diseases

3.45

2.89

1.3

1.2

—

Noninfective enteritis and colitis

265

1.70

2.89

1.1

1.2

—

Gout

124

1.99

2.88

1.1

1.2

—

Dialysis

4.11

2.88

1.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

115

2.09

2.87

1.1

1.2

—

Parkinson's disease

2.43

2.87

1.1

1.2

—

Venous thromboembolism

308

1.63

2.87

1.1

—

SLE, strict definition

5.41

2.87

1.1

1.5

—

SLE, ICD10

5.41

2.87

1.1

1.5

—

Carrier of infectious disease

6.70

2.87

1.2

1.6

—

Other intracranial haemorrhages

6.69

2.87

1.2

1.4

—

Rheumatoid arthritis, including avohilmo

200

1.80

2.84

1.1

1.2

—

Other obstetric conditions, not elsewhere classified

2.05

2.81

1.2

1.1

—

Crohn's disease of small intestine

3.34

2.81

1.0

1.3

—

Alcohol use disorder, ICD-based

238

1.72

2.79

1.2

1.1

—

Vitreous haemorrhage

2.65

2.79

1.0

1.2

—

L04AD Calcineurin inhibitors

2.65

2.79

1.1

1.2

—

Viral pneumonia

2.65

2.79

1.1

1.2

—

Benign neoplasm of other and unspecified endocrine glands

2.47

2.78

1.2

—

Benign neoplasm of brain and other parts of central nervous system

3.58

2.78

1.2

1.3

—

Abnormal findings on diagnostic imaging of other body structures

2.55

2.78

1.1

1.2

—

Gout, unspecified

110

2.09

2.77

1.1

1.2

—

Preparatory care for dialysis

3.93

2.77

1.2

1.3

—

Crohn disease (strict definition, all UC cases excluded)

3.92

2.77

1.0

1.3

—

Diabetic maculopathy

2.47

2.77

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

384

1.45

2.77

1.1

—

Other sleep disorders

3.08

2.76

1.1

—

KRA_PSY_EATING, excluding more controls

3.90

2.76

1.0

1.2

—

Other specified/unspecified necrotizing vasculopathies

8.40

2.75

1.2

1.3

—

Other diseases of the digestive system

173

1.85

2.75

1.1

1.2

—

Dyshidrosis [pompholyx]

8.39

2.75

1.2

1.8

—

IBD patients in KELA-register

124

2.02

2.75

1.1

—

Osteoporosis

122

1.99

2.74

1.0

1.2

—

Implicit fungal Sepsis

5.02

2.73

1.0

1.2

—

All anxiety disorders

260

1.61

2.72

1.2

1.1

—

Parkinson's disease, including avohilmo

2.36

2.72

1.1

1.2

—

Migraine with aura and triptan purchases

2.36

2.72

1.2

1.1

—

Shoulder lesions

283

1.52

2.71

1.1

—

Inflammatory bowel disease, strict (require KELA)

125

2.00

2.69

1.1

—

Sequelae of external causes of morbidity and mortality

125

2.00

2.69

1.2

—

Other/unspecified dorsalgia

180

1.82

2.69

1.1

1.2

—

Tuberculosis, IBD comorbidity

3.46

2.69

1.0

1.3

—

Tuberculosis, wide

3.46

2.69

1.0

1.3

—

Disorders of conjunctiva

406

1.48

2.69

1.2

1.1

—

Hypopituitarism

3.45

2.69

1.2

—

Calculus of lower urinary tract

3.76

2.67

1.0

1.2

—

Crohn's disease of large intestine

3.76

2.67

1.1

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

374

1.42

2.66

1.1

—

Gout, strict definition

2.18

2.66

1.1

1.2

—

Streptococcal septicaemia

3.15

2.64

1.2

1.3

—

Irritable bowel syndrome

140

1.93

2.64

1.3

1.1

—

Tonsillectomy and adenotomy

203

1.65

2.63

1.0

1.2

—

Diseases of inner ear

324

1.58

2.62

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.01

2.62

1.2

1.1

—

Anxiety (asthma-related co-morbidities)

245

1.61

2.62

1.2

1.1

—

Inflammatory bowel disease

169

1.84

2.61

1.1

—

Benign neoplasm: Cerebral meninges

2.93

2.61

1.0

1.2

—

Somatoform disorder

2.46

2.61

1.1

1.2

—

Other diseases of blood and blood-forming organs, wide

113

2.04

2.60

1.3

1.2

—

Reactive arthropathies, FINNGEN

3.34

2.60

1.0

1.2

—

Exposure to other and unspecified inanimate mechanical forces

3.34

2.60

1.1

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

266

1.53

2.60

1.2

1.1

—

Other heart diseases, wide

364

1.44

2.59

1.1

1.2

—

Acute sinusitis

253

1.65

2.59

1.3

1.1

—

Allergic asthma (mode)

2.31

2.59

1.1

—

Kidney transplant status

3.61

2.57

1.1

1.3

—

Non-Hodgkin lymphoma, all

4.01

2.57

1.3

—

Convergent concomitant strabismus

4.01

2.56

1.1

1.3

—

Cardiac arrest

3.67

2.56

1.0

1.1

—

Benign neoplasm: Brain, supratentorial

7.19

2.55

1.0

1.6

—

Non-selective monoamine reuptake inhibitors

171

1.80

2.55

1.2

—

Deficiency of other B group vitamins

7.18

2.55

1.0

1.6

—

Tuberculosis of other organs, strict

7.17

2.55

1.0

1.3

—

Functional dyspepsia

149

1.88

2.55

1.0

1.1

—

Conjunctivitis

367

1.50

2.55

1.2

1.1

—

Systemic lupus erythematosus, unspecified

5.48

2.54

1.2

1.5

—

Focal brain injury

5.46

2.54

1.0

—

Transplanted organ and tissue status

2.86

2.54

1.2

—

Other disorders of penis

2.73

2.54

1.0

1.2

—

Hypertensive diseases

272

1.49

2.53

1.1

—

Hypertension

272

1.49

2.53

1.1

—

Asthma (only as main-diagnosis), excluding more controls

176

1.62

2.52

1.2

1.1

—

Extracorporeal dialysis

3.24

2.51

1.1

1.2

—

Gout, idiopatic and unspecified

136

1.91

2.49

1.1

1.2

—

Menorrhagia

100

1.83

2.48

1.2

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.20

2.47

1.0

1.1

—

Acute and transient psychotic disorders

2.38

2.46

1.1

1.2

—

Reimbursement for rheumatic diseases

332

1.56

2.45

1.2

1.1

—

Other peripheral vertigo

2.67

2.45

1.2

—

Other and unspecified visual disturbances

2.67

2.45

1.2

—

Diseases of the digestive system

262

1.63

2.45

1.1

—

Diseases of peritoneum

2.55

2.44

1.0

1.2

—

Hypotension

2.24

2.43

1.1

1.2

—

Benign neoplasms

350

1.42

2.43

1.1

—

Sicca syndrome [Sjögren]

2.90

2.41

1.1

1.2

—

Chronic sinusitis

226

1.68

2.41

1.3

1.1

—

Fracture of rib(s), sternum and thoracic spine

174

1.78

2.41

1.0

1.2

—

Nonorganic sleeping disorders, excluding more controls

2.17

2.40

1.0

1.1

—

Adrenocortical insufficiency

5.02

2.40

1.2

1.4

—

Gout, FINNGEN

152

1.84

2.39

1.1

1.2

—

Tongue abnormality

3.34

2.39

1.1

1.3

—

Other and unspecified injuries of head

3.34

2.39

1.2

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

299

1.47

2.38

1.2

1.1

—

Communicating hydrocephalus

6.28

2.37

1.0

1.3

—

Retinoschisis and retinal cysts

6.28

2.37

1.0

1.4

—

Patent foramen ovale

6.28

2.37

1.2

1.5

—

Obesity due to excess calories

258

1.63

2.37

1.2

1.1

—

Other facial nerve disorders

6.27

2.37

1.0

1.5

—

Varicella [chickenpox]

3.64

2.36

1.1

1.2

—

Obesity and other hyperalimentation

355

1.52

2.36

1.2

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

5.31

2.35

1.0

1.1

—

Chronic diseases of tonsils and adenoids

296

1.47

2.35

1.1

—

Reactive arthropathies

2.83

2.34

1.1

1.2

—

Follow-up examination after treatment for malignant neoplasms

2.82

2.34

1.0

1.1

—

Other and unspecified urticaria

2.09

2.32

1.3

1.1

—

Unspecified misadventure during surgical and medical care

3.22

2.30

1.3

—

Lymphoid leukaemia

3.22

2.30

1.1

1.3

—

Other follicular disorders

3.22

2.30

1.3

1.2

—

Familial hypercholesterolemia

2.18

2.30

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

142

1.84

2.30

1.1

—

Enthesopathies of lower limb, excluding foot

105

2.00

2.30

1.2

—

Fissure and fistula of anal and rectal regions

126

1.91

2.30

1.1

1.2

—

Vascular dementia

3.22

2.29

1.6

1.3

—

Dental operations

182

1.55

2.28

1.2

1.1

—

Other enthesopathies

148

1.83

2.27

1.3

1.1

—

Injuries to the wrist and hand

455

1.39

2.27

1.2

1.1

—

Abnormal spermatozoa

2.46

2.27

1.2

—

Chondrocostal junction syndrome [Tietze]

4.63

2.27

1.0

1.5

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

3.49

2.27

1.3

—

Urticaria and erythema

200

1.70

2.27

1.2

1.1

—

Other and unspecified dermatitis

301

1.56

2.25

1.2

1.1

—

Angina pectoris

273

0.54

2.25

1.3

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

314

1.53

2.23

1.2

1.1

—

GI-bleeding

171

1.76

2.23

1.1

1.2

—

Mixed connective tissue disease

3.11

2.22

1.1

1.3

—

Other/unspecified reactive arthropathies

3.11

2.22

1.0

1.3

—

Fall on and from stairs and steps

142

1.83

2.22

1.1

1.2

—

Malignant neoplasm of breast, ER-positive, including Hilmo

125

1.79

2.21

1.0

1.2

—

Cerebral aneurysm, nonruptured

2.86

2.20

1.1

1.2

—

Other infectious diseases

2.69

2.20

1.3

1.2

—

Maternal care for other conditions predominantly related to pregnancy

2.08

2.17

1.2

1.1

—

Obesity

355

1.50

2.17

1.2

1.1

—

Urticaria

158

1.77

2.16

1.2

1.1

—

Impingement syndrome of shoulder

129

1.86

2.16

1.3

1.2

—

Disorders of vestibular function (Vertigo)

276

1.57

2.16

1.1

—

5-aminosalicylic acid

2.02

2.15

1.2

1.1

—

Erosion and ectropion of cervix uteri

4.30

2.15

1.3

1.1

—

Complications of other internal prosthetic devices, implants and grafts

4.30

2.15

1.3

1.4

—

Carpal tunnel syndrome

310

1.51

2.15

1.2

1.1

—

Obsessive-compulsive disorder

3.69

2.15

1.3

1.2

—

Disorders of calcium metabolism

3.01

2.14

1.1

1.2

—

Other disorders of eyelid

245

1.59

2.14

1.2

1.1

—

Postpartum care and examination

2.32

2.12

1.1

—

Asthma (only as main-diagnosis)

187

1.55

2.12

1.2

1.1

—

Degenerative diseases of the nervous system

137

1.72

2.11

1.2

1.1

—

Benign neoplasm: Colon, unspecified

130

1.85

2.11

1.1

1.2

—

Use of donepezil

2.05

2.10

1.2

1.1

—

Other superficial mycoses

2.45

2.10

1.2

—

Other and unspecified nonorganic psychotic disorders

102

1.96

2.09

1.1

—

Other and unspecified effects of external causes

145

1.79

2.09

1.1

—

Dyspnoea

425

1.39

2.09

1.2

1.1

—

Cluster headache, strict, including avohilmo

3.21

2.09

1.1

1.3

—

Cluster headache, wide,, including avohilmo

3.21

2.09

1.1

1.3

—

Urolithiasis

175

1.72

2.08

1.1

1.2

—

Other diseases of spinal cord

5.02

2.07

1.2

1.5

—

Use of galantamine

2.91

2.07

1.0

1.2

—

Cardiac arrhythmias

197

1.55

2.07

1.0

1.1

—

Undetermined asthma, excluding more controls

2.70

2.06

1.5

1.1

—

Benign neoplasm: Colon

317

1.51

2.06

1.1

1.2

—

Systemic atrophies primarily affecting the central nervous system

3.51

2.05

1.3

—

Varicella [chickenpox]

3.51

2.05

1.1

1.3

—

Brain meningioma, including Hilmo

3.51

2.05

1.0

1.4

—

2.32

2.04

1.3

1.1

—

Infective dermatitis

2.40

2.02

1.0

1.2

—

Neuralgia and neuritis, unspecified

3.08

2.01

1.3

1.2

—

Hyperkalaemia

3.08

2.01

1.0

1.3

—

Tuberculosis

3.08

2.01

1.0

1.3

—

Osteoporosis with pathological fracture (FG)

3.08

2.01

1.0

1.1

—

Other disorders of amniotic fluid and membranes

2.31

2.01

1.2

1.1

—

Subarachnoid haemorrhage

2.50

2.01

1.0

1.2

—

Fentanyl

2.50

2.00

1.0

1.2

—

Hyperlipidaemia, other/unspecified

205

1.62

2.00

1.2

1.1

—

Malignant neoplasm of breast, HER-positive

125

1.75

2.00

1.0

1.2

—

Other and unspecified psoriasis

2.82

2.00

1.2

1.3

—

DVT of lower extremities

2.00

1.2

—

Other disorders of bone

1.96

1.99

1.1

1.2

—

Other cataract

191

1.59

1.99

1.2

—

Biguanides

373

1.37

1.99

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.96

1.98

1.2

1.1

—

Acute suppurative otitis media

124

1.81

1.97

1.1

—

Residual foreign body in soft tissue

3.34

1.96

1.1

1.3

—

Respiratory tuberculosis, confirmed and not-confirmed

3.34

1.96

1.0

1.3

—

Respiratory tuberculosis

3.34

1.96

1.0

1.3

—

Septal defects

3.02

1.96

1.3

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.33

1.96

1.1

1.3

—

Early onset COPD

112

1.88

1.95

1.2

—

Diabetic retinopathy

123

1.67

1.95

1.2

1.1

—

Thyroiditis, ILD-related definition

2.36

1.94

1.2

—

Excessive attrition of teeth

321

1.50

1.94

1.1

—

Cluster headache, strict

4.56

1.94

1.2

—

Sequelae of injuries of head

2.97

1.93

1.0

1.3

—

Other disorders of adrenal gland

3.76

1.93

1.2

1.4

—

Schizophrenia, schizotypal and delusional disorders

172

1.69

1.92

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

269

1.49

1.92

1.1

1.2

—

Methotrexate

2.24

1.90

1.3

1.2

—

Superficial injury of abdomen, lower back and pelvis

2.05

1.90

1.0

1.2

—

Radiculopathy

2.05

1.90

1.0

1.2

—

Viral and other specified intestinal infections

123

1.80

1.90

1.1

—

Hypothyroidism, strict autoimmune

258

1.45

1.89

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

143

1.75

1.88

1.1

—

Gingivitis and periodontal diseases

353

1.34

1.87

1.2

1.1

—

Poisoning by medicine

114

1.84

1.86

1.0

1.1

—

Invasive ventilation

2.65

1.86

1.0

1.2

—

Disorders of the thyroid gland

388

1.36

1.85

1.1

—

Solid cancers, helper endpoint

311

1.39

1.84

1.1

1.2

—

Sequelae of injuries of neck and trunk

3.54

1.84

1.0

1.3

—

Immunodeficiency with predominantly antibody defects

4.18

1.82

1.6

1.5

—

Secondary parkinsonism+Parkinsonism in other disease

4.18

1.82

1.0

1.3

—

Cluster headache, wide

4.18

1.82

1.2

—

Ectropion of eyelid

4.18

1.82

1.2

1.1

—

Combinations of oral blood glucose lowering drugs

160

1.69

1.81

1.2

—

Spondylopathies (FG)

2.27

1.80

1.3

1.2

—

Immunodeficiencies

3.05

1.80

1.4

1.3

—

Special screening examination for other diseases and disorders

2.57

1.79

1.0

1.1

—

Use of hypnotics and sedatives

417

1.32

1.79

1.1

1.2

—

Biological medication for rheuma

1.96

1.79

1.1

—

Acute peritonitis

2.76

1.79

1.0

1.3

—

Other and unspecified mood [affective] disorders

2.76

1.79

1.1

1.2

—

Congenital malformations of cardiac septa

2.77

1.79

1.3

—

Other diseases of upper respiratory tract

369

1.33

1.78

1.2

1.1

—

384

1.32

1.77

1.2

1.1

—

Disorders of sclera, cornea, iris and ciliary body

320

1.47

1.77

1.2

1.1

—

Candidiasis

2.09

1.75

1.1

1.2

—

Hyperfunction of pituitary gland

3.34

1.74

2.2

1.3

—

Anorexia (incl.atypical)

3.34

1.74

1.0

1.3

—

Eustachian salpingitis and obstruction

2.50

1.74

1.0

1.2

—

Foreign body entering into or through eye or natural orifice

2.50

1.74

1.1

1.2

—

Eating disorder

2.50

1.73

1.0

1.2

—

Viral pneumonia (unknown virus, not influenza)

2.67

1.72

1.1

1.2

—

Acne vulgaris

2.67

1.72

1.1

1.2

—

Hypermetropia

2.92

1.72

1.3

—

Intermittent heterotropia

2.92

1.72

1.1

1.3

—

Secondary parkinsonism

3.86

1.71

1.0

1.3

—

Hypogonadotropic hypogonadism

3.86

1.71

1.0

1.4

—

Chronic hepatitis, not elsewhere classified

3.86

1.71

1.2

1.3

—

Dissociative [conversion] disorders

3.85

1.71

1.0

1.3

—

Otitis externa, unspecified

2.13

1.71

1.0

1.2

—

Malignant neoplasm

317

1.36

1.69

1.1

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

216

1.56

1.68

1.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

1.68

0.0

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

375

1.31

1.68

1.1

—

Endometriosis ASRM stages 3,4

111

1.80

1.68

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

203

1.58

1.67

1.2

1.1

—

Unspecified/other endometriosis

2.50

1.66

1.1

—

Special screening examination for neoplasms

3.16

1.66

1.2

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

346

1.41

1.66

1.1

1.2

—

Postpartum haemorrhage

1.84

1.65

1.1

—

Keratitis

188

1.60

1.65

1.3

1.1

—

Other diseases of liver

1.89

1.64

1.1

1.2

—

Statin medication

231

1.41

1.64

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.03

1.64

1.3

1.1

—

Undetermined asthma

2.44

1.64

1.5

1.1

—

Endometriosis of ovary

1.93

1.63

1.1

—

Ptosis of eyelid

2.25

1.63

1.3

1.1

—

Schizophrenia or delusion

173

1.62

1.63

1.0

1.1

—

Cough

216

1.53

1.62

1.3

1.1

—

Other/unspecified rheumatoid arthritis

2.15

1.61

1.1

1.2

—

Other strabismus

1.83

1.59

1.3

1.1

—

210

1.53

1.59

1.2

—

Other (not insulin) diabetes medications

363

1.32

1.58

1.1

—

Other and unspecified disorders of white blood cells

3.01

1.58

1.2

1.3

—

Separation of retinal layers (serosa)

3.01

1.58

1.2

1.3

—

Brain meningioma

3.01

1.58

1.0

1.4

—

Desensitization to allergens

3.00

1.58

1.5

1.3

—

Other disorders of white blood cells

2.70

1.58

1.4

1.3

—

Vulvovaginal ulceration/inflammation in other diseases

2.70

1.58

1.1

1.2

—

Atopic dermatitis, strict definition

141

1.67

1.56

1.1

—

Disorders of vitreous body and globe

300

1.44

1.56

1.0

1.2

—

Disorders of vitreous body

294

1.45

1.55

1.0

1.2

—

Endometriosis

105

1.62

1.55

1.1

—

Sarcoidosis

2.03

1.54

1.4

1.2

—

Spondyloarthritis

1.92

1.53

1.2

—

Thyrotoxicosis, other and/or unspecified

100

1.80

1.52

1.2

1.1

—

Spinal instabilities

3.34

1.52

1.0

1.4

—

Unknown and unspecified causes of morbidity

3.34

1.52

1.2

—

COPD (mode)

113

1.67

1.52

1.2

1.1

—

Medicines for HER+ breast cancer

182

1.56

1.52

1.0

1.1

—

Abnormal findings on antenatal screening of mother

2.60

1.51

1.1

1.2

—

Symptoms and signs concerning food and fluid intake

2.59

1.51

1.0

1.2

—

Hypermobility syndrome

2.86

1.50

1.0

1.2

—

Sequelae of other external causes

2.86

1.50

1.0

1.3

—

Burns and corrosions of external body surface, specified by site

2.16

1.50

1.1

1.2

—

Haemangioma, any site

0.00

1.49

0.0

1.2

—

Paroxysmal tachycardia

1.82

1.46

1.1

—

Substance use, excluding alcohol

109

1.74

1.46

1.1

—

Viral and other specified intestinal infections

1.78

1.46

1.1

1.2

—

Other diseases of pleura

241

1.46

1.2

—

Eating disorders

2.22

1.45

1.0

1.2

—

Nonsuppurative otitis media

1.75

1.44

1.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

123

1.69

1.44

1.0

1.2

—

Nonorganic sleeping disorders

102

1.77

1.44

1.0

1.1

—

Asthma and allergy, excluding more controls

2.34

1.44

1.1

—

Other specified/unspecified dorsopathies

3.13

1.44

1.0

1.4

—

Optic neuritis

3.13

1.44

1.2

1.3

—

Non-small cell lung cancer, squamous

3.13

1.44

1.2

—

Foreign body in alimentary tract

2.73

1.43

1.2

1.3

—

Lateral epicondylitis

2.04

1.43

1.1

1.2

—

Panic disorder

1.97

1.43

1.1

1.2

—

Peripheral artery operations in Hilmo

1.97

1.43

1.1

1.2

—

Left bundle-branch block

2.31

1.43

1.1

1.2

—

Tinnitus

118

1.70

1.41

1.1

—

Other fall from one level to another

118

1.70

1.40

1.2

—

Sequelae with surgical and medical care as external cause

103

1.75

1.40

1.2

—

Ocular pain

2.25

1.40

1.3

1.2

—

Use of disulfiram, acamprosate or naltrexone

2.25

1.40

1.1

1.2

—

Other complications of surgical and medical care, not elsewhere classified

2.25

1.40

1.2

—

Fenamates

1.94

1.38

1.2

1.1

—

Diseases of arteries, arterioles and capillaries

317

1.35

1.38

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

321

1.32

1.38

1.1

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1.94

1.38

1.1

1.2

—

Postpartum hemorraghe, parous women as controls

1.72

1.37

1.1

—

conjunctival haemorrhage

2.20

1.37

1.0

1.2

—

Corneal ulcer

1.80

1.37

1.3

1.2

—

Hypercalcemia

2.61

1.37

1.2

1.3

—

Convalescence

2.61

1.36

1.0

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

142

1.51

1.36

1.0

1.2

—

Malignant neoplasm of breast, including Hilmo

142

1.51

1.36

1.0

1.2

—

Thyrotoxicosis

127

1.65

1.36

1.2

1.1

—

Chronic conjunctivitis

2.95

1.36

1.6

1.4

—

Right bundle-branch block

2.95

1.36

1.4

—

Benign neoplasm: Skin of ear and external auricular canal

2.95

1.36

1.6

1.4

—

Other noninflammatory disorders of cervix uteri

2.95

1.36

1.4

1.1

—

Non-small cell lung cancer, squamous, helper endpoint

2.95

1.36

1.2

1.1

—

Spondylosis

255

1.41

1.35

1.1

1.2

—

Sulfonylureas

157

1.52

1.35

1.1

1.2

—

Asthma and allergy

2.17

1.35

1.1

—

Chronic periodontitis, complicated

337

1.38

1.34

1.1

1.2

—

Antepartum haemorrhage, not elsewhere classified

0.00

1.34

0.0

1.1

—

Acute bronchitis

227

1.47

1.34

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative

139

1.51

1.33

1.0

1.2

—

Nail disorders

2.15

1.33

1.4

1.2

—

Amputation

2.13

1.33

1.1

1.2

—

Irregular menses

182

1.48

1.33

1.2

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.83

1.33

1.1

1.2

—

Unspecified privation

2.04

1.32

1.1

1.2

—

Fracture of lower leg, including ankle

304

1.40

1.32

1.1

—

Secondary uncertain malignant neoplasm

2.04

1.32

1.0

1.3

—

Personality disorders, excluding more controls

105

1.71

1.32

1.1

—

Acute upper respiratory infections

416

1.27

1.32

1.2

1.1

—

Actinic keratosis

192

1.50

1.32

1.2

—

Injuries to the hip and thigh

255

1.42

1.32

1.2

1.1

—

Diaphragmatic hernia

208

1.49

1.32

1.2

—

Chondropathies

1.81

1.31

1.1

1.2

—

Smoking dependency

2.10

1.30

1.2

—

Deep endometriosis

2.10

1.30

1.1

1.2

—

Excessive, frequent and irregular menstruation

112

1.52

1.29

1.3

1.1

—

Tumor necrosis factor alpha inhibitors

1.84

1.29

1.0

1.2

—

Poisoning by drugs, medicaments and biological substances

129

1.63

1.29

1.0

1.1

—

Other noninflammatory disorders of uterus, except cervix

1.73

1.29

1.3

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

200

1.48

1.29

1.2

—

Other and unspecified abdominal hernia

2.78

1.28

1.0

1.4

—

Clear cell adenocarcinoma of kidney

2.78

1.28

1.2

—

Abnormal findings on examination of urine, without diagnosis

2.78

1.28

1.0

1.3

—

Other diseases of peritoneum

2.78

1.28

1.0

1.4

—

Contusion of other and unspecified parts of foot

2.78

1.28

1.4

1.2

—

Noninfectious colitis NAS

1.89

1.28

1.0

1.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.46

1.28

1.3

1.1

—

Acute alcohol intoxication, ICD10

114

1.67

1.28

1.1

1.2

—

Sudden idiopathic hearing loss

2.09

1.27

1.1

1.2

—

Diseases of middle ear and mastoid

266

1.38

1.27

1.0

1.1

—

FESS (DNB20)

1.94

1.27

1.4

1.1

—

Superficial injury of wrist and hand

1.72

1.26

1.1

—

Acute pancreatitis

1.72

1.26

1.3

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.79

1.26

1.1

—

Other symptoms and signs involving the circulatory and respiratory systems

2.29

1.26

1.3

1.1

—

Neuromuscular dysfunction of bladder

2.29

1.26

1.0

1.1

—

Mental and behavioural disorders due to tobacco

2.05

1.26

1.2

—

Malignant neoplasm of breast

141

1.48

1.25

1.0

1.2

—

Postpartum hemorraghe, all women as controls

113

1.66

1.24

1.1

—

Lesion of lateral popliteal nerve

2.40

1.24

1.3

1.2

—

Autoimmune hyperthyroidism

2.40

1.24

1.0

1.2

—

Otalgia

2.23

1.24

1.0

1.2

—

Assault by bodily force

2.22

1.24

1.1

1.2

—

Infectious mononucleosis

2.22

1.24

1.0

1.2

—

Spontaneous rupture of synovium and tendon

2.22

1.24

1.4

1.2

—

Disorders of parathyroid gland

1.74

1.24

1.0

1.2

—

Temporomandibular joint disorders, including avohilmo

233

1.44

1.23

1.2

1.1

—

Acute alcohol intoxication

139

1.58

1.22

1.1

1.2

—

Atopic dermatitis

262

1.38

1.22

1.2

1.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

2.64

1.21

1.2

1.4

—

Noise effects on inner ear

2.64

1.21

1.6

1.2

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

2.64

1.21

1.0

1.3

—

Disorders of refraction and accommodation

131

1.60

1.21

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

314

1.36

1.21

1.2

1.1

—

252

1.42

1.21

1.2

1.1

—

Spinal stenosis

224

1.39

1.19

1.2

—

Burns and corrosions

1.83

1.19

1.1

1.2

—

Hernia

413

1.27

1.19

1.1

—

Other ulcerative colitis

2.31

1.18

1.5

1.3

—

Endovascular or surgical operations to intracerebral aneurysms

2.31

1.18

1.0

1.2

—

Retinal detachments and breaks

197

1.47

1.18

1.1

1.2

—

Other/unspecified enthesopathies, not elsewhere classified

2.11

1.18

1.5

1.2

—

Respiratory insufficiency

2.30

1.18

1.2

1.1

—

Acne

2.10

1.18

1.1

1.2

—

Assault

1.88

1.18

1.4

1.1

—

Hypothyroidism, other/unspecified

365

1.28

1.17

1.1

—

Calculus of kidney and ureter

165

1.52

1.17

1.1

1.2

—

Other diseases of anus and rectum

165

1.51

1.16

1.2

—

Other endocrine disorders

2.52

1.15

1.4

1.3

—

Erectile dysfunction

2.05

1.15

1.1

1.2

—

Ingrowing nail

2.50

1.15

1.4

—

Maltreatment syndromes

2.50

1.15

1.4

1.2

—

Hypertrophic disorders of skin

2.50

1.15

1.6

1.3

—

Abscess of anal and rectal regions

2.05

1.15

1.0

1.3

—

Personal history of malignant neoplasm

2.50

1.15

1.2

—

Otitis externa

110

1.64

1.15

1.1

—

Pleural effusion

1.81

1.15

1.2

—

Malignant neoplasm of colon, including Hilmo

1.72

1.14

1.1

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

389

1.26

1.14

1.1

—

Diseases of oral cavity, salivary glands and jaws

191

1.35

1.14

1.1

1.2

—

Alcohol dependence

142

1.55

1.14

1.2

—

Peripheral arterial reconstruction

1.75

1.12

1.0

1.1

—

Excessive vomiting in pregnancy

2.00

1.12

1.6

1.1

—

Transient global amnesia

2.00

1.12

1.0

1.2

—

Seborrhoeic dermatitis

2.00

1.12

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

111

1.62

1.11

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

159

1.51

1.11

1.3

1.2

—

Glucagon-like peptide-1 (GLP-1) analogues

159

1.51

1.11

1.3

1.2

—

Familial hypercholesterolemia, with ischemic heart disease

1.96

1.11

1.5

1.2

—

Gestational diabetes (for exclusion)

115

1.51

1.11

1.1

—

Other diseases of stomach and duodenum

2.26

1.10

1.6

1.2

—

Complications following abortion and ectopic and molar pregnancy

2.39

1.09

1.0

1.3

—

Scabies

2.38

1.09

1.2

—

Erosion of teeth , including avohilmo

138

0.51

1.09

1.0

1.1

—

Acute pancreatitis (for exclusion)

104

1.64

1.09

1.3

1.2

—

Inflammatory disease of uterus

1.82

1.08

1.2

1.1

—

Alcohol abuse, main dg, excluding more controls

1.82

1.08

1.0

1.2

—

Chronic gastritis

144

1.53

1.08

1.1

1.2

—

Mental and behavioural disorders due to sedatives or hypnotics

2.19

1.08

1.1

1.2

—

Squamous cell neoplasms and carcinomas of the skin

2.19

1.08

1.3

1.1

—

Atrial fibrillation and flutter with reimbursement

1.64

1.07

1.0

1.1

—

Non-small cell lung cancer

1.94

1.07

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1.69

1.07

1.0

1.2

—

Suppurative and unspecified otitis media

171

1.45

1.07

1.1

—

Adverse effects, not elsewhere classified

1.65

1.06

1.1

—

Achilles tendinitis

1.93

1.06

1.3

1.2

—

Benign paroxysmal vertigo

145

1.52

1.05

1.0

1.2

—

False labour

1.58

1.04

1.2

1.1

—

Chronic pancreatitis

1.79

1.04

1.2

—

Ethmoidectomy

1.79

1.04

1.4

1.1

—

Restless leg syndrome

1.79

1.04

1.2

1.1

—

Glucosamine medication

222

1.37

1.04

1.2

—

Gonarthrosis

216

1.32

1.03

1.2

—

Pustular psoriasis

2.28

1.03

1.0

1.4

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

2.28

1.03

1.4

1.3

—

Episcleritis

2.28

1.03

1.2

1.3

—

Psychotic depression

2.27

1.03

1.0

1.1

—

Benign neoplasm of urinary organs

2.28

1.03

1.0

1.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

2.06

1.02

1.0

1.2

—

Diabetes mellitus in pregnancy

1.56

1.01

1.3

1.1

—

Emotionally unstable personality disorder

1.89

1.01

1.0

1.2

—

Other diseases of arteries and capillaries

1.88

1.00

1.1

1.2

—

Chalazion

1.88

1.00

1.1

—

Abnormal findings on examination of blood, without diagnosis

266

1.35

1.00

1.1

1.2

—

Coxarthrosis [arthrosis of hip](FG)

215

1.34

0.99

1.1

1.2

—

Insomnia

396

1.25

0.99

1.0

1.1

—

Conduction disorders

152

1.44

0.99

1.1

1.2

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.60

0.98

1.1

—

Meniscus derangement

212

1.33

0.98

1.2

1.1

—

Olecranon bursitis

0.00

0.97

0.0

1.2

—

Gonarthrosis [arthrosis of knee](FG)

264

1.28

0.97

1.2

1.1

—

Rotator cuff syndrome

264

1.30

0.97

1.2

—

Any event in cancer register

341

1.24

0.97

1.1

1.2

—

Ulcerative proctitis

0.00

0.97

0.0

1.2

—

Sulfasalazine

140

1.50

0.97

1.1

—

Contact with other sharp object(s)

1.95

0.97

1.3

1.2

—

Fibromyalgia

1.95

0.97

1.4

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.63

0.97

1.0

1.1

—

Deforming dorsopathies

132

1.52

0.96

1.2

—

Nonalcoholic fatty liver disease

1.80

0.96

1.2

—

Benign neoplasm of eye and adnexa

1.80

0.96

1.1

1.2

—

Superficial injury of shoulder and upper arm

1.80

0.96

1.2

—

Other/unspecified synovitis and tenosynovitis

1.80

0.96

1.7

1.2

—

Type 2 diabetes, definitions combined

351

1.24

0.96

1.1

—

Ulcerative colitis, NAS

1.74

0.96

1.2

—

Asthma-related pneumonia or sepsis

198

1.41

0.96

1.3

1.1

—

Asthma, hospital admissions 3, pneumonia

198

1.41

0.96

1.3

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

301

1.32

0.96

1.2

1.1

—

Caries of dentine, including avohilmo

264

1.26

0.95

1.2

1.1

—

Haemorrhage from respiratory passages

179

1.41

0.95

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

349

1.23

0.94

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

1.77

0.94

1.0

1.2

—

Other skin changes

1.65

0.94

1.4

1.2

—

Allergic urticaria

1.89

0.94

1.0

1.2

—

Disorders of tooth development and eruption

1.70

0.93

1.2

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

1.61

0.93

1.1

1.2

—

Suppurative and necrotic conditions of lower respiratory tract

2.23

0.93

1.0

1.3

—

Fracture of neck

2.23

0.93

1.0

1.3

—

Lesion of plantar nerve

2.23

0.93

1.2

—

Alcohol-induced chronic pancreatitis

2.23

0.93

1.3

—

Failed induction of labour

2.22

0.93

1.3

1.1

—

Social phobias

2.22

0.93

1.3

1.2

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

204

0.67

0.92

1.1

—

Type 2 diabetes, strict (exclude DM1)

353

1.23

0.92

1.1

—

Use of other anti-dementia drugs

110

1.51

0.92

1.1

—

Use of memantine

110

1.51

0.92

1.1

—

Alcoholic liver disease

1.73

0.92

1.1

1.2

—

Disorders of continuity of bone

1.73

0.92

1.1

1.2

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1.73

0.92

1.3

1.1

—

Cirrhosis of liver, NAS

2.15

0.91

1.0

1.2

—

Need for other prophylactic measures

2.15

0.91

1.2

1.3

—

Postmenopausal osteoporosis with pathological fracture

2.15

0.91

1.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS